Substance Name: Dostarlimab [USAN]
RN: 2022215-59-2
UNII: P0GVQ9A4S5
Molecular Formula
- C6420-H9832-N1680-O2014-S44 (non-glycosylated)
Classification Code
- Treatment of Cancer
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Dostarlimab [USAN]
Synonyms
- Dostarlimab
- Immunoglobulin G4-kappa, anti-(human programmed cell death proptein 1 (protein PD-1, CD279 antigen)); humanized monoclonal antibody: gamma4 heavy chain (1-440) (humanized VH (Homo sapiens IGHV3-23*01 (92%) -(IGHD)-IGHJ6*01 (93%)) (8.8.6) (1-113) -Homo sapiens IGHG4*01 (CH1 C27>G(140), H87>K(200), K88>H(201), H S10>P(221)) (114-440)) (127-214')-disulfide with kappa light chain (1'-214') (humanized V-KAPPA (Homo sapiens IGKV1-39*01 (92%) -IGKJ4*01) (6.3.9) (1'-107') -Homo sapiens IGKC*01 (107'-214')), dimer (219-219'':222-222'')-bisdisulfide
- TSR-042
- UNII-P0GVQ9A4S5
- WBP-285
Systematic Name
- Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 2022215-59-2
FDA UNII
- P0GVQ9A4S5
System Generated Number
- 2022215592